Biodexa pharmaceuticals plc (“biodexa” or the “company”) notice of general meeting

May 22, 2025 biodexa pharmaceuticals plc (“biodexa” or the “company”) notice of general meeting biodexa pharmaceuticals plc, (nasdaq: bdrx), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs announces a notice of a general meeting to be held at the company's offices, 1 caspian point, caspian way, cardiff, cf10 4dq on 11 june 2025 at 1.00pm was posted to shareholders today. the board of directors is proposing four resolutions: ordinary resolutions       1.
BDRX Ratings Summary
BDRX Quant Ranking